08:00 , Jan 20, 2014 |  BC Week In Review  |  Company News

BioBlocks, Visionary Pharmaceuticals deal

The companies partnered to discover and develop small molecule inhibitors of serum/glucocorticoid regulated kinase 1 (SGK1) to treat cancer. The partners said the kinase has been implicated in breast, prostate, colorectal and non-small cell lung...
08:00 , Nov 24, 2008 |  BC Week In Review  |  Company News

BioBlocks, MannKind deal

The companies extended by one year their January 2007 deal to use BioBlocks' medicinal chemistry technology to perform lead optimization for MannKind against undisclosed targets. The partnership has already met an undisclosed preclinical milestone. Financial...